A Randomized Controlled Trial of the Group-Based Modified Story Memory Technique in TBI

Impairments in new learning and memory (NLM) are common deficits in individuals with Traumatic Brain Injury (TBI) and exert significant negative impact on everyday life. There is thus a need for effective interventions for learning and memory dysfunction in TBI, particularly group-based interventions for which 3rd party payment may be more forthcoming, The current study addresses this need through a double blind, placebo-controlled, randomized clinical trial (RCT) of a group administration of the modified Story Memory Technique (mSMT). Over a decade of research and development at our center has demonstrated the mSMT to be effective for improving NLM in individuals with Multiple Sclerosis (MS) and TBI across three realms of functioning, objective behavior, brain functioning and everyday life. This convincing data provides Class I evidence supporting the efficacy of the mSMT for improving NLM in these populations. Given the strong efficacy data on the mSMT, coupled with the current trends in insurance reimbursement, clinicians worldwide have highlighted the need to provide the mSMT via an effective group format. We have thus modified the treatment protocol for group administration.